Tumour model

DEL

Diffuse large B cells lymphoma DLBCL
XenograftIn vitro

DEL cells

Human DEL cells were isolated from a pleural effusion of a patient with malignant histiocytosis.

Tumour growth in vivo

The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of NSG mice. The resulting tumours were monitored by measuring two diameters with calipers, and extrapolating the volume to a sphere.

The mice bearing DEL tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or subcutaneous injection of the compounds. Per os administration is also possible.

Figure 1: (view PDF) Tumour growth curve of the DEL cells as subcutaneous tumors. Mean ± SEM (n=3

Luciferase model in vivo

Antineo has developed a DEL luciferase positive cell line for tumor growth follow-up with a luminescence imager (IVIS Lumina).  The cells were implanted subcutaneously in 3 mice (10 x 106 cells).

Figure 3: (view PDF) Bioluminescent signal of DEL cells for Mouse 2

Figure 4: (view PDF) Bioluminescent signal of DEL cells for Mouse 3 (primary tumor and metastasis)

Download PDF

Model characteristics

Organism
Human
Tissue of origin
B cells
Pathology
Diffuse large B cells lymphoma DLBCL
Model type
In vitro, Xenograft
Availability
Off the shelf (time of expansion)

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Mouse
B cells
Lymphoma
SyngeneicIn vitro
Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro
Human
B cells
Mantle cells lymphoma
XenograftIn vitro
Human
B cells
Burkitt's lymphoma
XenograftIn vitroResistant
Human
B cells
Diffuse large B cells lymphoma DLBCL
XenograftIn vitro
Human
B cells
Mantle cells lymphoma
XenograftIn vitro